[{"address1": "900 North Point Parkway", "address2": "Suite 200", "city": "Alpharetta", "state": "GA", "zip": "30005", "country": "United States", "phone": "678 270 3631", "fax": "678 270 4033", "website": "https://clearsidebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 836154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles A. Deignan", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 568676, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jenny R. Kobin", "age": 57, "title": "Head of Investor Relations", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rick  McElheny", "title": "Senior Vice President of Corporate Development & Alliance Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rafael V. Andino", "age": 59, "title": "Senior Vice President of Engineering & Manufacturing", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ngai Hang  Chong FRCOphth, FRCS, M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leslie B. Zacks J.D.", "age": 55, "title": "Secretary", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7491, "open": 0.75, "dayLow": 0.7409, "dayHigh": 0.779, "regularMarketPreviousClose": 0.7491, "regularMarketOpen": 0.75, "regularMarketDayLow": 0.7409, "regularMarketDayHigh": 0.779, "payoutRatio": 0.0, "beta": 2.039, "forwardPE": -1.5298, "volume": 231422, "regularMarketVolume": 231422, "averageVolume": 206452, "averageVolume10days": 190110, "averageDailyVolume10Day": 190110, "bid": 0.7369, "ask": 0.8036, "bidSize": 1, "askSize": 1, "marketCap": 59007376, "fiftyTwoWeekLow": 0.7, "fiftyTwoWeekHigh": 1.65, "priceToSalesTrailing12Months": 35.461163, "fiftyDayAverage": 0.94018, "twoHundredDayAverage": 1.05853, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 98870872, "profitMargins": 0.0, "floatShares": 67269456, "sharesOutstanding": 77143904, "sharesShort": 735552, "sharesShortPriorMonth": 571295, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0095999995, "heldPercentInsiders": 0.12821001, "heldPercentInstitutions": 0.19769, "shortRatio": 2.99, "shortPercentOfFloat": 0.010199999, "impliedSharesOutstanding": 77143904, "bookValue": -0.507, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -34352000, "trailingEps": -0.47, "forwardEps": -0.5, "enterpriseToRevenue": 59.418, "enterpriseToEbitda": -3.45, "52WeekChange": -0.40697676, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 0.7649, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 20020000, "totalCashPerShare": 0.26, "ebitda": -28656000, "totalDebt": 52470000, "quickRatio": 4.282, "currentRatio": 4.438, "totalRevenue": 1664000, "revenuePerShare": 0.023, "returnOnAssets": -0.61042, "grossProfits": 1515000, "freeCashflow": -22482124, "operatingCashflow": -24698000, "revenueGrowth": -0.952, "grossMargins": 0.91046, "ebitdaMargins": 0.0, "operatingMargins": -23.36275, "financialCurrency": "USD", "symbol": "CLSD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Clearside Biomedical, Inc.", "longName": "Clearside Biomedical, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1464874200000, "postMarketChangePercent": 3.28147, "postMarketPrice": 0.79, "postMarketChange": 0.0251, "regularMarketChange": 0.0158, "regularMarketDayRange": "0.7409 - 0.779", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 206452, "fiftyTwoWeekLowChange": 0.06490004, "fiftyTwoWeekLowChangePercent": 0.09271435, "fiftyTwoWeekRange": "0.7 - 1.65", "fiftyTwoWeekHighChange": -0.88509995, "fiftyTwoWeekHighChangePercent": -0.5364242, "fiftyTwoWeekChangePercent": -40.697678, "earningsTimestamp": 1743105900, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1743107400, "earningsCallTimestampEnd": 1743107400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.5, "epsCurrentYear": -0.45286, "priceEpsCurrentYear": -1.689043, "fiftyDayAverageChange": -0.17527997, "fiftyDayAverageChangePercent": -0.18643236, "twoHundredDayAverageChange": -0.29362994, "twoHundredDayAverageChangePercent": -0.2773941, "priceToBook": -1.5086784, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744402905, "regularMarketTime": 1744401601, "exchange": "NGM", "messageBoardId": "finmb_145617165", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.1091976, "regularMarketPrice": 0.7649, "displayName": "Clearside Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]